CN Patent

CN108752254B — 2-[1-(乙基磺酰基)-3-氮杂环丁亚基]乙腈的制备方法

Assigned to Daohe Weifang Pharmaceutical Technology Co ltd · Expires 2021-11-02 · 5y expired

What this patent protects

本发明涉及医药化学技术领域，具体涉及巴瑞克替尼四元环中间体的制备方法；本发明还提供了一种在微通道反应器中进行的绿色的氧化反应；本发明提供的工艺路线中原料易得、经济绿色环保且适合工业化生产。

USPTO Abstract

本发明涉及医药化学技术领域，具体涉及巴瑞克替尼四元环中间体的制备方法；本发明还提供了一种在微通道反应器中进行的绿色的氧化反应；本发明提供的工艺路线中原料易得、经济绿色环保且适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108752254B
Jurisdiction
CN
Classification
—
Expires
2021-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Daohe Weifang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.